Beyond Air/XAIR

$1.28

-3.75%
-
1D1W1MYTD1YMAX

About Beyond Air

Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Company’s LungFit platform can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections through delivery through a breathing mask or similar apparatus. The Company’s areas of focus with LungFit are persistent pulmonary hypertension of the newborn (PPHN), viral community-acquired pneumonia (VCAP), including COVID-19, bronchiolitis (BRO), nontuberculous mycobacteria (NTM) lung infection and various severe lung infections with underlying chronic obstructive pulmonary disease (COPD). Its LungFit PH is an ionizer technology that generates on-demand NO from ambient air and, regardless of dose or flow, delivers it to a ventilator circuit. The LungFit can generate up to 400 parts per million (ppm) of NO.

Ticker

XAIR

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Steven Lisi

Employees

98

Headquarters

Garden city, United States

Beyond Air Metrics

BasicAdvanced
$59.67M
Market cap
-
P/E ratio
-$2.13
EPS
-0.11
Beta
-
Dividend rate
$59.67M
-0.11426
$6.40
$1.17
298.54K
3.388
3.256
69.088
69.713
-112.64%
-185.9%
-148.49%
86.601
2.216
3.086
-14.02%

What the Analysts think about Beyond Air

Analyst Ratings

Majority rating from 6 analysts.
Buy

Price Targets

Average projection from 6 analysts.
837.5% upside
High $19.00
Low $7.00
$1.28
Current price
$12.00
Average price target

Beyond Air Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-5,400% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$300K
50%
Net income
$-16.2M
-0%
Profit margin
-5,400%
-33.33%

Beyond Air Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.66%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.67
-$0.45
-$0.51
-$0.50
-
Expected
-$0.47
-$0.47
-$0.47
-$0.53
-$0.49
Surprise
43.06%
-3.57%
8.9%
-5.66%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Beyond Air stock?

Beyond Air (XAIR) has a market cap of $59.67M as of April 17, 2024.

What is the P/E ratio for Beyond Air stock?

The price to earnings (P/E) ratio for Beyond Air (XAIR) stock is 0 as of April 17, 2024.

Does Beyond Air stock pay dividends?

No, Beyond Air (XAIR) stock does not pay dividends to its shareholders as of April 17, 2024.

When is the next Beyond Air dividend payment date?

Beyond Air (XAIR) stock does not pay dividends to its shareholders.

What is the beta indicator for Beyond Air?

Beyond Air (XAIR) has a beta rating of -0.11. This means that it has an inverse relation to market volatility.

What is the Beyond Air stock price target?

The target price for Beyond Air (XAIR) stock is $12, which is 837.5% above the current price of $1.28. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Beyond Air stock

Buy or sell Beyond Air stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing